Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
An ex-FBI agent analyzes what we learned from Savannah Guthrie's 'Today' show interview amid the search for her mother Nancy - 2Heartfelt Objections to Visit with Your Adored One
- 3Minute Maid’s frozen juice concentrate is ending after 80 years — and so is a certain kind of kitchen ritual
- 4What to know about new CDC deputy director who has been critical of COVID vaccines
- 5Astronomers detect rare 'free floating' exoplanet 10,000 light-years from Earth
- Moving Pool Highlights for 2024
- Iran plans new restrictions in overhaul of Strait of Hormuz rules
- The most effective method to Guarantee Thorough Inclusion in Senior Protection.
- National health ranking puts Georgia near bottom of list. Here's why
- ‘The White Lotus’ sparked online interest in risky anxiety pills, study says
- Artemis II astronauts arrive at Florida launch site for first moon trip in 53 years
- What did the gov’t approve for Israel’s 2026 state budget?
- NASA will bring space station crew home early after medical issue
- Birds Will Flock To Your Birdbath When You Plant These Two Flowers Around It
